Patents by Inventor Edward T. Joseph

Edward T. Joseph has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8343084
    Abstract: A wound closure apparatus and associated methods are provided which utilize blood fluid by activating the clotting cascade of blood fluid within a substantially enclosed sterile container then introducing the blood fluid to the wound site to complete clotting. An apparatus for providing ways of inhibiting anticoagulating agents and slowing fibrin clot degradation are also disclosed. Kits are also disclosed. The invention provides a clotting cascade initiation apparatus including a substantially enclosed sterile containment chamber within which an aliquot of blood fluid, either autologous or from donor sources, can be received and retained. In preferred embodiments, the sterile containment chamber further includes a heparin binding agent which will bind heparin and remove it from the blood fluid. In further embodiments, the containment chamber will also include a procoagulating agent, wherein a clotting cascade can be initiated when the blood fluid is accepted into the sterile containment chamber.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: January 1, 2013
    Assignee: Closys Corporation
    Inventors: Karol L. Nowakowski, James E. Olson, Edward T. Joseph, Daniel G. Ericson
  • Publication number: 20110046574
    Abstract: A wound closure apparatus is provided which utilizes blood fluid by activating the clotting cascade of blood fluid outside the body within a substantially enclosed sterile container then introducing the blood fluid to the wound site to complete clotting. An apparatus for providing ways of inhibiting anticoagulating agents and slowing fibrin clot degradation are also disclosed. Kits for practicing the invention singularly or in combination with and/or associated with preferred procedures are also disclosed. The invention provides a clotting cascade initiation apparatus including a substantially enclosed sterile containment chamber within which an aliquot of blood fluid, either autologous or from donor sources, can be received and retained. In preferred embodiments, the sterile containment chamber further includes a heparin binding agent which will bind heparin and remove it from the blood fluid.
    Type: Application
    Filed: October 29, 2010
    Publication date: February 24, 2011
    Inventors: Karol L. Nowakowski, James E. Olson, Edward T. Joseph, Daniel G. Ericson
  • Publication number: 20030069601
    Abstract: Wound closure methods and apparatus are provided which utilize blood fluid by activating the clotting cascade of blood fluid outside the body within a substantially enclosed sterile container then introducing the blood fluid to the wound site to complete clotting. Methods and apparatus for providing ways of inhibiting anti-coagulating agents and slowing fibrin clot degradation are also disclosed. Kits for practicing the invention singularly or in combination with and/or associated with preferred procedures are also disclosed. The present invention provides improved methods of creating hemostasis or control of bleeding at the site of wounds, particularly wounds created in arteries during procedures employing percutaneous access. The invention preferably includes the steps of acquiring an aliquot of a patient's blood, i.e.
    Type: Application
    Filed: November 12, 2002
    Publication date: April 10, 2003
    Applicant: Closys Corporation
    Inventors: Karol L. Nowakowski, James E. Olson, Edward T. Joseph, Daniel G. Ericson
  • Patent number: 6482223
    Abstract: Wound closure methods and apparatus are provided which utilize blood fluid by activating the clotting cascade of blood fluid outside the body within a substantially enclosed sterile container then introducing the blood fluid to the wound site to complete clotting. Methods and apparatus for providing ways of inhibiting anti-coagulating agents and slowing fibrin clot degradation are also disclosed. Kits for practicing the invention singularly or in combination with and/or associated with preferred procedures are also disclosed. The present invention provides improved methods of creating hemostasis or control of bleeding at the site of wounds, particularly wounds created in arteries during procedures employing percutaneous access. The invention preferably includes the steps of acquiring an aliquot of a patient's blood, i.e.
    Type: Grant
    Filed: June 1, 2000
    Date of Patent: November 19, 2002
    Assignee: Closys Corporation
    Inventors: Karol L. Nowakowski, James E. Olson, Edward T. Joseph, Daniel G. Ericson
  • Patent number: 6015419
    Abstract: A surgical instrument includes a hollow handle having an end slot and a side slot and a blade carrier securable to a scalpel blade and moveable between first and second positions relative to the handle. One of the first and second positions is an extended, in-use position wherein the scalpel blade extends out of the handle through the end slot. The other position is a retracted, non-use position wherein the scalpel blade is wholly disposed within the handle. At least one finger extends from the blade carrier and has a first contoured portion engageable, when the blade carrier is in the first position, with a second contoured portion of the handle. The first and second contoured portions are substantially complementary such that the finger must deflect to permit disengagement of the first contoured portion of the finger from the second contoured portion of the handle so that the blade carrier can be moved from the first position toward the second position.
    Type: Grant
    Filed: August 31, 1998
    Date of Patent: January 18, 2000
    Assignee: Strome Steel Surgical, Inc.
    Inventors: Scott E. Strome, Edward T. Joseph